MedPath

Sigilon Therapeutics, Inc.

Sigilon Therapeutics, Inc. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2015-01-01
Employees
101
Market Cap
-
Website
http://www.sigilon.com

Clinical Trials

2

Active:1
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy

Phase 1
Withdrawn
Conditions
MPS1-S
MPS I
MPS1-HS
First Posted Date
2022-12-27
Last Posted Date
2023-04-11
Lead Sponsor
Sigilon Therapeutics, Inc.
Registration Number
NCT05665036
Locations
🇬🇧

Clinical Study Site, Salford, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.